The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2020

Filed:

May. 12, 2016
Applicants:

Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;

Universite DE Nantes, Nantes, FR;

Centre Hospitalier Universitaire DE Nantes, Nantes, FR;

Inventors:

Carole Guillonneau, Nantes, FR;

Ignacio Anegon, Nantes, FR;

Severine Bezie, Nantes, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); G01N 33/569 (2006.01); G01N 33/68 (2006.01); C12N 5/0783 (2010.01); A61K 35/17 (2015.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
G01N 33/505 (2013.01); A61K 35/17 (2013.01); C12N 5/0637 (2013.01); G01N 33/56972 (2013.01); G01N 33/6869 (2013.01); A61K 2035/122 (2013.01); C12N 2501/2334 (2013.01); G01N 2333/7051 (2013.01); G01N 2333/70514 (2013.01); G01N 2333/70517 (2013.01); G01N 2333/70589 (2013.01); G01N 2800/245 (2013.01);
Abstract

Disclosed is a method for labeling, detecting and/or isolating Foxp3+ Treg cells from a biological sample containing peripheral blood mononuclear cells (PBMC) or lymphocytes including the following steps of: (i) coupling the surface of PBMC or lymphocytes to a capture moiety which binds to the cell through a cell surface molecule and to interleukin-34 (IL34), (ii) culturing the lymphocytes under conditions wherein IL34 is secreted, released and specifically captured by the capture moiety, (iii) labeling the IL34 expressing lymphocytes with a label moiety, and (iv) optionally detecting and/or isolating the IL34 expressing lymphocytes which are Foxp3+ Treg cells. Also disclosed is an isolated population of Foxp3+ Treg cells obtainable by the method and uses thereof.


Find Patent Forward Citations

Loading…